BEGIN:VCALENDAR
METHOD:PUBLISH
VERSION:2.0
CALSCALE:GREGORIAN
PRODID:-//NONSGML WPForms//NONSGML Sugar Calendar Feeds v3.11.1//EN
X-WR-CALNAME:Partnering with Curie.Bio: Turning Ideas into Therapies
X-WR-CALDESC:The Milner Therapeutics Institute
X-WR-TIMEZONE:Europe/London
BEGIN:VTIMEZONE
TZID:Europe/London
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
DTSTART:20251026T010000
TZNAME:GMT
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
DTSTART:20260329T010000
TZNAME:BST
END:DAYLIGHT
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/London
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
DTSTART:20251026T010000
TZNAME:GMT
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
DTSTART:20260329T010000
TZNAME:BST
END:DAYLIGHT
END:VTIMEZONE
BEGIN:VEVENT
SUMMARY:Partnering with Curie.Bio: Turning Ideas into Therapies
DESCRIPTION:Turning Ideas into Therapies: an opportunity to connect with
  a leading therapeutics investor Curie.Bio\n&#x1f5d3\;&#xfe0f\;  16 Ap
 ril   &#x23f0\; 12:00-1:30pm\n&#x1f4cd\; Lecture Theatre\, Jeffrey Che
 ah Biomedical Centre\n\nJoin the Milner Therapeutics Institute and Ca
 mbridge Enterprise for a seminar showcase and networking event with the
  leadership team at US venture firm Curie.Bio.\n\nCurie.Bio is a US ven
 ture capital firm and accelerator that helps founders discover and devel
 op novel therapeutics. The company was created with the aim of removing 
 the typical bottlenecks and boundaries that get in the way of creating d
 rugs. To achieve this\, the company collaborates closely with founders t
 o reach better milestones in initial funding rounds\, which in turn incr
 ease founders’ probabilities of success.\n\nAt this event\, Christoph 
 Lengauer\, Founder and CSO\, and members of the leadership team will sho
 wcase Curie.Bio's differentiated approach including how they collaborate
  with founders\, illustrated by a Q&amp\;A with Prof Gabriel Balmus\, Gr
 oup Leader at the UK Dementia Institute and CEO at FunctionRx. The compa
 ny is working on discovering oral small molecule targeting MSH3 to halt 
 Huntington‘s disease and other repeat expansion disorders at a very ea
 rly stage.\n\nRegister at: tickettailor.com/events/milnerinstitute/2132
 156
URL;VALUE=URI:https://www.milner.cam.ac.uk/events/partnering-with-curie-
 bio-turning-ideas-into-therapies/
UID:urn:uuid:942676a3-6166-4e3d-b9ff-df795aab06f1
STATUS:CONFIRMED
ORGANIZER:
DTSTAMP:20260604T105232Z
DTSTART;TZID=Europe/London:20260416T120000
DTEND;TZID=Europe/London:20260416T133000
LOCATION:Puddicombe Way
END:VEVENT
END:VCALENDAR